Quintiles has introduced Allume, a go-to-market service designed to help biopharmaceutical companies efficiently launch new products and shorten timelines to sales. According to the company, Allume simplifies and organizes the complex and resource-intensive launch planning process, provides data-driven insights from 15 years of market entry experience across the globe, and leverages Quintiles’ local market and therapeutic category expertise.   Allume incorporates Quintiles’ biopharma product lau...